Trial Profile
A Phase 1 Pharmacokinetic Study To Compare the Relative Bioavailability of Two Clinical Formulations of Linifanib in Subjects With Solid Tumours.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Linifanib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Abbott Laboratories
- 21 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Jun 2011 New trial record